EBSAM
Eubel Brady & Suttman Asset Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,029
| Closed | -$216K | – | 98 |
|
|
2025
Q1 | $216K | Buy |
+1,029
| New | +$216K | 0.03% | 90 |
|
|
2024
Q4 | – | Sell |
-1,038
| Closed | -$205K | – | 91 |
|
|
2024
Q3 | $205K | Sell |
1,038
-676
| -39% | -$134K | 0.03% | 88 |
|
|
2024
Q2 | $294K | Buy |
+1,714
| New | +$294K | 0.04% | 79 |
|
|
2021
Q3 | – | Sell |
-831
| Closed | -$90K | – | 72 |
|
|
2021
Q2 | $90K | Buy |
+831
| New | +$90K | 0.01% | 262 |
|
|
2017
Q1 | – | Sell |
-5,507
| Closed | -$345K | – | 76 |
|
|
2016
Q4 | $345K | Hold |
5,507
| – | – | 0.1% | 62 |
|
|
2016
Q3 | $347K | Sell |
5,507
-210
| -4% | -$13.2K | 0.11% | 61 |
|
|
2016
Q2 | $354K | Sell |
5,717
-325
| -5% | -$20.1K | 0.12% | 55 |
|
|
2016
Q1 | $345K | Hold |
6,042
| – | – | 0.12% | 55 |
|
|
2015
Q4 | $358K | Buy |
6,042
+100
| +2% | +$5.93K | 0.12% | 56 |
|
|
2015
Q3 | $323K | Hold |
5,942
| – | – | 0.11% | 56 |
|
|
2015
Q2 | $399K | Hold |
5,942
| – | – | 0.13% | 49 |
|
|
2015
Q1 | $348K | Sell |
5,942
-120
| -2% | -$7.03K | 0.11% | 54 |
|
|
2014
Q4 | $397K | Buy |
6,062
+195
| +3% | +$12.8K | 0.12% | 49 |
|
|
2014
Q3 | $339K | Sell |
5,867
-280
| -5% | -$16.2K | 0.1% | 63 |
|
|
2014
Q2 | $347K | Hold |
6,147
| – | – | 0.1% | 54 |
|
|
2014
Q1 | $316K | Buy |
6,147
+325
| +6% | +$16.7K | 0.09% | 63 |
|
|
2013
Q4 | $307K | Buy |
5,822
+83
| +1% | +$4.38K | 0.09% | 60 |
|
|
2013
Q3 | $257K | Hold |
5,739
| – | – | 0.07% | 72 |
|
|
2013
Q2 | $237K | Buy |
+5,739
| New | +$237K | 0.07% | 74 |
|